Roivant Sciences Ltd. (ROIV)
About Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $8.3M
- Net income
- -$299.8M
- Total assets
- $5.7B
- Market cap
- $20.6B
- Operating margin
- -6235.7%
- Net margin
- -4817.3%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $8.3M
- Operating expenses
- $1.3B
- Operating income
- -$515.1M
- Income tax
- $133.3M
- Net income
- -$397.9M
- EPS (basic)
- $-0.43
- EPS (diluted)
- $-0.54
Balance sheet
- Total assets
- $5.7B
- Current assets
- $5.2B
- Total liabilities
- $416.3M
- Current liabilities
- $281.2M
- Shareholders’ equity
- $5.3B
Cash flow
- Operating cash flow
- -$750.3M
- Investing cash flow
- -$682.3M
- Financing cash flow
- $134.2M
- Net cash flow
- -$1.3B
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $20.6B
- EPS (diluted)
- $-0.54
- Shares outstanding
- 595.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 1, 2021
Roivant Sciences Ltd. (ROIV) Stock Price
- Reported a net loss of $299.8M in FY2026.
- Revenue declined 85% from FY2022 to FY2026.
- Trading 6% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Roivant Sciences Ltd..
Write a review
News about Roivant Sciences Ltd.
News & sentiment via Polygon.io
Roivant Sciences Ltd.: frequently asked questions
Is Roivant Sciences Ltd. an American company?
Roivant Sciences Ltd. is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Roivant Sciences Ltd. publicly traded?
Yes — Roivant Sciences Ltd. is a publicly traded company. Its stock trades under the ticker symbol ROIV on the NASDAQ.
What does Roivant Sciences Ltd. do?
Roivant Sciences Ltd. is an American Pharmaceuticals company in the Health & Beauty sector.
When was Roivant Sciences Ltd. founded?
Roivant Sciences Ltd. was founded in 2014.
